母亲1型糖尿病及混杂因素对新生儿微生物组的影响
该观察性病例对照研究对92对母婴(含50例1型糖尿病孕妇)的514份阴道、直肠、耳皮肤拭子和粪便样本行16S rRNA测序。结果显示1型糖尿病孕妇及其新生儿存在特异性微生物群;校正混杂因素后,新生儿耳皮肤微生物组变异与母亲1型糖尿病状态(p=0.020)和小于胎龄儿出生体重(p=0.050)相关;1型糖尿病孕妇孕早期HbA1c>55 mmol/mol(>7.2%)与新生儿耳皮肤微生物群组成相关(p=0.008)。
要点
- 1型糖尿病孕妇及其新生儿存在特异性微生物群。
- 不考虑母亲1型糖尿病状态时,分娩方式和产时抗生素预防均影响新生儿微生物群组成(均p=0.001)。
- 1型糖尿病孕妇孕早期HbA1c>55 mmol/mol(>7.2%)与新生儿耳皮肤微生物群组成相关(p=0.008)。
核心结论
- 除母亲1型糖尿病外,妊娠前/孕早期血糖控制不佳、分娩方式和产时抗生素预防可能参与新生儿微生物组的定植和形成。
研究设计与样本
- 观察性病例对照研究,共92对母婴(含50例1型糖尿病孕妇),采集514份阴道、直肠和耳皮肤拭子及粪便样本,用16S rRNA扩增子测序分析微生物群落组成和功能,并收集贯穿妊娠和分娩的详细临床元数据。
主要发现
- 在1型糖尿病孕妇及其新生儿中鉴定出1型糖尿病特异性微生物群。
- 不考虑母亲1型糖尿病状态时,分娩方式和产时抗生素预防均影响新生儿微生物群组成(均p=0.001)。
- 纳入所有混杂因素的logistic回归分析中,新生儿耳皮肤微生物组变异由母亲1型糖尿病状态(p=0.020)和小于胎龄儿出生体重(p=0.050)解释。
- 在1型糖尿病孕妇中,孕早期测量的HbA1c>55 mmol/mol(>7.2%)与新生儿耳皮肤微生物群组成相关(p=0.008)。
- PICRUSt评估中,碳水化合物生物合成相关通路被预测为1型糖尿病中失调的微生物功能谱关键要素;SourceTracker分析显示新生儿微生物群平均81.0%归因于母亲来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Body niche-specific microbiota in maternal-neonatal dyads from gravidae with type 1 diabetes have not been quantitatively and functionally examined. Similarly, the impact of pregnancy-specific factors, such as the presence of comorbidities known to occur more frequently among gravidae with type 1 diabetes, including Caesarean delivery, as well as antibiotic prophylaxis, level of glycaemic control during each trimester of pregnancy and insulin administration, has not been adequately considered. The aims of this study were to characterise the maternal and neonatal microbiomes, assess aspects of microbiota transfer from the maternal microbiomes to the neonatal microbiome and explore the impact of type 1 diabetes and confounding factors on the microbiomes. METHODS: In this observational case-control study, we characterised microbiome community composition and function using 16S rRNA amplicon sequencing in a total of 514 vaginal, rectal and ear-skin swabs and stool samples derived from 92 maternal-neonatal dyads (including 50 gravidae with type 1 diabetes) and in-depth clinical metadata from throughout pregnancy and delivery. RESULTS: Type 1 diabetes-specific microbiota were identified among gravidae with type 1 diabetes and their neonates. Neonatal microbiome profiles of ear-skin swabs and stool samples were established, indicating the taxa more prevalent among neonates born to mothers with type 1 diabetes compared with neonates born to control mothers. Without taking into account the type 1 diabetes status of mothers, both delivery mode and intrapartum antibiotic prophylaxis were found to have an influence on neonatal microbiota composition (both p=0.001). In the logistic regression analysis involving all confounding variables, neonatal ear-skin microbiome variation was explained by maternal type 1 diabetes status (p=0.020) and small for gestational age birthweight (p=0.050). Moreover, in women with type 1 diabetes, a relationship was found between HbA1c levels >55 mmol/mol (>7.2%) measured in the first trimester of pregnancy and neonatal ear-skin microbiota composition (p=0.008). In the PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) assessment, pathways concerning carbohydrate biosynthesis were predicted as key elements of the microbial functional profiles dysregulated in type 1 diabetes. Additionally, in SourceTracker analysis, we found that, on average, 81.0% of neonatal microbiota was attributed to maternal sources. An increase in the contribution of maternal rectum microbiota and decrease in the contribution of maternal cervix microbiota were found in ear-skin samples of vaginally delivered neonates of mothers with type 1 diabetes compared with neonates born to control mothers (83.2% vs 59.5% and 0.7% vs 5.2%, respectively). CONCLUSIONS/INTERPRETATION: These findings indicate that, in addition to maternal type 1 diabetes, glycaemic dysregulation before/in the first trimester of pregnancy, mode of delivery and intrapartum antibiotic prophylaxis may contribute to the inoculation and formation of the neonatal microbiomes. DATA AVAILABILITY: The BioProject (PRJNA961636) and associated SRA metadata are available at http://www.ncbi.nlm.nih.gov/bioproject/961636 . Processed data on probiotic supplementation and the PICRUSt analysis are available in the Mendeley Data Repository ( https://doi.org/10.17632/g68rwnnrfk.1 ).
引用
- Gajecka M, Gutaj P, Jaskiewicz K, et al. Effects of maternal type 1 diabetes and confounding factors on neonatal microbiomes. Diabetologia. 2023. PMID: 38030736. doi:10.1007/s00125-023-06047-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。